Policy & Advocacy Massachusetts at BIO 2025: Leaning on Strengths to Lead the Future of Life Sciences Jun 26, 2025
Press Releases U.S. Biotechnology, Massachusetts Leadership at Risk: New Report Warns of Major Disruption Across Innovation Pipeline May 06, 2025
Policy & Advocacy MassBio Statement on President Trump’s executive order on drug pricing Apr 16, 2025
Policy & Advocacy Statement on CMS listing 15 additional drugs subject to price negotiations Jan 17, 2025
Policy & Advocacy Post-Election Healthcare and Biotech Outlook: Implications for Massachusetts and Beyond Dec 05, 2024
